Treatment Sequencing Strategies in Lung Cancer.
Background and objective The advances in the lung cancer screening methods and therapeutics, together with awareness towards deleterious habits, such as smoking, is increasing the overall survival with better quality of life for the patients. However, lung cancer is still one of the most common and...
| Publicado en: | Chinese Journal of Lung Cancer Vol. 25; no. 5; pp. 323 - 337 |
|---|---|
| Autores principales: | , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Chinese Journal of Lung Cancer
May2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156995011&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 156995011 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10093419 9014 jtl: Chinese Journal of Lung Cancer issn: 10093419 maglogo: N pubinfo: dt: May2022 vid: 25 iid: 5 pid: 54191 pub: Chinese Journal of Lung Cancer artinfo: ui: 156995011 156995011 156995011 10.3779/j.issn.1009-3419.2022.104.01 156995011 ppf: 323 ppct: 14 formats: fmt: @attributes: type: P tig: atl: Treatment Sequencing Strategies in Lung Cancer. aug: au: Pozza, Daniel Humberto Bezerra Andrade de Mello, Ramon affil: Department of Biomedicine, Faculty of Medicine and i3s, University of Porto, 4200-319 Porto, Portugal sug: subj: Lung Neoplasms Therapy Oncologic Care Patient Care Plans Guideline Adherence Human Lung Neoplasms Physiopathology Histocytochemistry Pathology, Molecular Immunotherapy Antibodies, Monoclonal Therapeutic Use Nivolumab Therapeutic Use Systematic Review PubMed Genetic Techniques ab: Background and objective The advances in the lung cancer screening methods and therapeutics, together with awareness towards deleterious habits, such as smoking, is increasing the overall survival with better quality of life for the patients. However, lung cancer is still one of the most common and fatal neoplasm with a high incidence and consequently burden to public health worldwide. Thus, based on guidelines and recent phases II and III clinical trials studies, this manuscript summarizes the current treatment sequencing strategies in lung cancer. Methods A comprehensive search of related articles was performed focused on phases II and III clinical trials studies. Results The lung cancer management should take into consideration the tumor characteristics, histology, molecular pathology and be discussed in a multidisciplinary team. Lung cancer treatment options comprises surgery whenever possible, radiotherapy associate with/or chemotherapy and immunotherapy as monotherapy, or combined with chemotherapy and best palliative care. Conclusions The screening predictability in more patients, smoking reduction, early diagnosis, better disease understanding and individualized, more effective and tolerable therapeutics are related to an increasing in overall survival and quality of life. In the near future improvement of personalized therapy in precision medicine is expected, enhancing new predictive biomarkers, optimal doses and optimal treatment sequencing as well as anti-cancer vaccines development. pubtype: Academic Journal doctype: research systematic review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|